Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

A conservative approach in a penetrating eye injury with an intraocular foreign body

Poster Details

First Author: S. Diafas GREECE

Co Author(s):    D. Kapantais   K. Stamoulas   A. Lioura   D. Panagiotou   G. Mpalanikas   P. Oikonomidis     

Abstract Details

Purpose:

Prompt removal of retained intraocular foreign bodies (IOFB) after a penetrating ocular trauma is accepted to be crucial in the prevention of bacterial endophthalmitis. Furthermore capsular injury from an IOFB most times results in cataract formation. Our purpose is to present a case with a penetrating ocular trauma with an IOFB which was managed conservatively without a surgical procedure uneventfully.

Setting:

1st Department of Ophthalmology, AHEPA University Hospital, Thessaloniki, Greece.

Methods:

A 58 year old male patient suffering from a penetrating injury of his right eye with an IOFB in the anterior cortex of his crystalline lens was managed conservatively with the placement of a soft bandage contact lens and topical antibiotic, antifungal, cycloplegic and steroid eye drops.

Results:

At the follow-up after 3 days and after the contact lens removal, the corneal laceration healed completely with negative seidel and Tyndal’s phenomenon. His left eye showed no signs of cataract formation or inflammation.

Conclusions:

The effective conservative management of the penetrating injury with an IOFB that was followed in our case (without a phaco and prophylactic intravitreal or systemic antibiotics) probably proved that the foreign body’s substance was inert and that maybe at some occasions, after a penetrating eye injury with an IOFB, a less invasive approach, under close monitoring, is possible.

Financial Disclosure:

NONE

Back to Poster listing